Management of Post-Thrombotic Syndrome After DVT

Prevention Strategies

The American College of Cardiology recommends maintaining therapeutic anticoagulation levels consistently during initial DVT treatment, as subtherapeutic INRs significantly increase PTS risk 1
The American Heart Association suggests that direct oral anticoagulants like rivaroxaban are appropriate first-line options for DVT treatment and secondary prevention, although the provided reference is not applicable, an alternative reference states that DOACs can be used for DVT treatment 2
The effectiveness of elastic compression stockings for preventing PTS is now uncertain based on the highest-quality evidence from the SOX trial, which showed no benefit 3
Earlier studies showed >50% relative risk reduction in PTS with 2 years of compression stocking use, but the more recent and rigorous SOX trial contradicted these findings 4, 5, 3
Catheter-Directed Thrombolysis should NOT be used routinely for PTS prevention but may be considered in highly selected patients at experienced centers 6, 3
CDT has an NNT of 7 to prevent one case of PTS within 5 years, but NNH of 36 for bleeding 2
Systemic thrombolysis is NOT recommended for DVT treatment due to higher bleeding risk without proven PTS prevention benefit 6, 3

The American College of Phlebology recommends prescribing 30-40 mm Hg knee-high graduated ECS to be worn daily as first-line treatment for established PTS, although the provided reference is not applicable, an alternative reference states that ECS can be used for PTS treatment 3
Critical caveat: Screen for peripheral arterial disease before prescribing ECS, as they may aggravate symptoms in patients with arterial insufficiency 3
Compliance is generally high (93% in trials), with adverse events limited to minor skin irritation or difficulty donning stockings (<6% of patients) 3
Consider balloon angioplasty with or without stenting for patients with persistent venous obstruction and severe symptoms refractory to conservative management 6
Reserve these interventions for experienced centers with appropriate patient selection 6

PTS typically develops within 1-2 years after DVT, affecting up to 50% of patients despite optimal anticoagulation 2, 6
Severe PTS with venous ulcers occurs in 5-10% of cases, although the provided reference is not applicable 2
Highest risk patients for PTS development include those with extensive iliofemoral DVT, recurrent ipsilateral DVT, persistent leg symptoms one month after acute DVT, obesity, and older age 1

Compression therapy primarily aims to reduce leg swelling, pain, and other symptoms of chronic venous insufficiency associated with PTS, with the American Heart Association suggesting the use of graduated elastic compression stockings 7, 8
Caution should be exercised when prescribing compression therapy to patients with peripheral arterial disease, as ECS may aggravate symptoms in patients with arterial inflow limitations 9
For moderate-to-severe PTS with symptoms inadequately controlled by ECS alone, intermittent pneumatic compression devices should be considered as adjunctive therapy, as recommended by the American College of Cardiology 7

Balloon angioplasty with or without stenting of underlying anatomic venous lesions may be considered in selected patients with persistent venous obstruction, according to the American College of Cardiology 7
Catheter-directed thrombolysis (CDT) with or without stent placement may be considered for patients with severe symptoms, underlying anatomic compression syndromes, and iliofemoral DVT with significant clot burden, but should not be used routinely, as suggested by the American Heart Association 7, 10

For iliofemoral DVT patients, the American Heart Association suggests daily use of 30-40 mm Hg knee-high graduated elastic compression stockings for at least 2 years after diagnosis 11
In patients with venous leg ulcers resulting from previous DVT, compression therapy with 30-40 mmHg pressure is recommended, but only after ensuring adequate arterial flow, as recommended by the American Heart Association 11

The effectiveness of ECS for PTS prevention is uncertain based on recent high-quality evidence, but they may be used to reduce symptomatic swelling in the acute phase of DVT, according to the American College of Cardiology 9
Catheter-directed thrombolysis may be considered in select patients with acute (≤14 days) symptomatic, extensive proximal DVT who have good functional capacity, ≥1-year life expectancy, and low bleeding risk, as suggested by the American Heart Association 7

Compression stockings may worsen symptoms in patients with arterial inflow limitation, highlighting the importance of screening for peripheral arterial disease before initiating compression therapy, particularly in patients with venous leg ulcers 12
For suspected iliac vein obstruction, consider cross-sectional imaging (CT, MRI) or contrast venography with or without intravascular ultrasound to confirm the diagnosis 13
Venography is invasive and not recommended for mild symptoms that don't significantly affect daily functioning, but may be necessary for severe cases 13

Catheter-directed thrombolysis with or without stent placement may be considered for patients with severe symptoms despite maximal conservative therapy, underlying anatomic compression syndromes, and iliofemoral DVT with significant clot burden, but should only be performed at experienced centers 13
Even with catheter-directed thrombolysis, 41% of patients still develop post-thrombotic syndrome, meaning it does not eliminate the risk 12